Q. Which are the top players in this liquid biopsy market?
Which are the top players in this liquid biopsy market?
The liquid biopsy market was valued at US$ 2.4 billion in 2021 and is expected to grow at a CAGR of 18% during 2022-2028 to reach US$ 7.64 billion in 2028.
What is Liquid Biopsy?
Liquid biopsy, also known as fluid biopsy or fluid phase biopsy, is the sampling and analysis of non-solid biological tissue, mainly blood. This technique is mainly used as a diagnostic and monitoring tool for diseases such as cancer, with the added benefit of being largely non-invasive.
Market Drivers
Increase in the number of cancer patients,
Increasing demand for non-invasive treatment procedures,
Growing awareness about the benefits of liquid biopsy,
Advantages such as low cost, rapid and accurate results, and early detection of diseases.
Read More: https://www.stratviewresearch.com/42...

